The teratogenic potential of sucralose was examined following gavage admini
stration to pregnant rats and rabbits during organogenesis, Groups of 20 ma
ted rats mere dosed on days 6-15 of gestation inclusive at 500, 1000 or 200
0 mg/kg/day; groups of 16 to 18 inseminated rabbits mere dosed on days 6 to
19 of gestation inclusive at 175, 350 or 700 mg/kg/day following prelimina
ry studies at higher doses. Concurrent control groups received vehicle alon
e. Rats were killed on day 21 and rabbits on day 29 of gestation. Foetuses
were evaluated at necropsy and after processing for possible soft tissue an
d skeletal alterations. There,vas no evidence of teratogenicity for either
species. The only observed response to treatment in rats was a slight incre
ase in water intake. Some adult rabbits receiving 700 mg/kg/day exhibited m
arked gastrointestinal disturbance, also seen at higher doses in preliminar
y studies. Gastrointestinal effects such as these occur non-specifically in
response to high doses of poorly absorbed compounds, and in the present st
udy mere considered to be responsible for two maternal deaths and four abor
tions. Full evaluation of rabbit foetuses in the main study (up to 700 mg/k
g/day) and necropsy of foetuses in a preliminary study with pregnant animal
s (up to 1000 mg/kg/day) showed no evidence of adverse foetal response to s
ucralose. These teratology studies in both pregnant rodent and non-rodent a
nimal models demonstrate that maternal consumption of high levels of sucral
ose during the period of organogenesis has no effect on normal foetal devel
opment in the rat or rabbit. (C) 2000 Elsevier Science Ltd. All rights rese
rved.